These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Familial incidence of precipitating antibodies in von Willebrand's disease: a study of four cases. Ruggeri ZM; Ciavarella N; Mannucci PM; Molinari A; Dammacco F; Lavergne JM; Meyer D J Lab Clin Med; 1979 Jul; 94(1):60-75. PubMed ID: 112210 [TBL] [Abstract][Full Text] [Related]
4. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757 [TBL] [Abstract][Full Text] [Related]
5. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease. Chediak J; Peake I; Bloom A Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844 [TBL] [Abstract][Full Text] [Related]
6. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease. Holmbeg L; Nilsson IM Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718 [TBL] [Abstract][Full Text] [Related]
7. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
8. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease. Sultan Y; Simeon J; Caen JP J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003 [TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
10. Investigation including VIIIR: AG multimeric analysis of a large kindred with type IIA von Willebrand's disease showing a dominant inheritance and similar gene expression in four generations. Hill FG; Enayat MS; George AJ Thromb Haemost; 1983 Oct; 50(3):735-9. PubMed ID: 6417821 [TBL] [Abstract][Full Text] [Related]
11. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
12. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families. Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576 [No Abstract] [Full Text] [Related]
13. Variant von Willebrand's disease. A study emphasizing crossed-immunoelectrophoresis. Green D; Philip KJ Thromb Haemost; 1980 Feb; 43(1):2-5. PubMed ID: 6967636 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120). Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753 [TBL] [Abstract][Full Text] [Related]
15. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. Gralnick HR; Coller BS; Sultan Y J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491 [TBL] [Abstract][Full Text] [Related]
16. [Factor VIII complex activities in acute leukemia]. Pniejnia-Olszyński W; Lopaciuk S Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320 [TBL] [Abstract][Full Text] [Related]
17. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740 [TBL] [Abstract][Full Text] [Related]
19. Differences between heterozygous dominant and recessive von Willebrand's disease type I expressed by bleeding symptoms and combinations of factor VIII variables. Wahlberg TB; Blombäck M; Ruggeri ZM Thromb Haemost; 1983 Dec; 50(4):864-8. PubMed ID: 6420925 [TBL] [Abstract][Full Text] [Related]
20. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease. Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]